These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


144 related items for PubMed ID: 30696999

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Trends in hematopoietic stem cell transplant activity in Lebanon.
    Bazarbachi A, Zahreddine A, Massoud R, El Cheikh J, Hanna C, Nasr F, Abboud M, Ibrahim A.
    Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):315-320. PubMed ID: 28641098
    [Abstract] [Full Text] [Related]

  • 3. Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies.
    Valcárcel D, Martino R, Sureda A, Canals C, Altés A, Briones J, Sanz MA, Parody R, Constans M, Villela SL, Brunet S, Sierra J.
    Eur J Haematol; 2005 Feb; 74(2):144-51. PubMed ID: 15654906
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Ten years after the first inspection of a candidate European centre, an EBMT registry analysis suggests that clinical outcome is improved when hematopoietic SCT is performed in a JACIE accredited program.
    Chabannon C, Pamphilon D, Vermylen C, Gratwohl A, Niederwieser D, McGrath E, Lamers C, Lanza F, Slaper-Cortenbach I, Madrigal A, Apperley J.
    Bone Marrow Transplant; 2012 Jan; 47(1):15-7. PubMed ID: 21383685
    [Abstract] [Full Text] [Related]

  • 7. Clinical utility of computed tomography screening of chest, abdomen, and sinuses before hematopoietic stem cell transplantation: the St. Jude experience.
    Kasow KA, Krueger J, Srivastava DK, Li C, Barfield R, Leung W, Horwitz EM, Madden R, Woodard P, Hussain I, McCarville MB, Handgretinger R, Hale GA.
    Biol Blood Marrow Transplant; 2009 Apr; 15(4):490-5. PubMed ID: 19285637
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of centre and period effects in allogeneic haematopoietic stem cell transplantation in France.
    Mesnil F, Jouet JP, Tuppin P, Vernant JP, Golmard JL.
    Bone Marrow Transplant; 2004 Oct; 34(7):645-51. PubMed ID: 15300230
    [Abstract] [Full Text] [Related]

  • 9. Introduction of a quality management system and outcome after hematopoietic stem-cell transplantation.
    Gratwohl A, Brand R, Niederwieser D, Baldomero H, Chabannon C, Cornelissen J, de Witte T, Ljungman P, McDonald F, McGrath E, Passweg J, Peters C, Rocha V, Slaper-Cortenbach I, Sureda A, Tichelli A, Apperley J.
    J Clin Oncol; 2011 May 20; 29(15):1980-6. PubMed ID: 21483006
    [Abstract] [Full Text] [Related]

  • 10. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
    Sun Y, Meng F, Han M, Zhang X, Yu L, Huang H, Wu D, Ren H, Wang C, Shen Z, Ji Y, Huang X.
    Biol Blood Marrow Transplant; 2015 Jun 20; 21(6):1117-26. PubMed ID: 25840339
    [Abstract] [Full Text] [Related]

  • 11. Use of the quality management system "JACIE" and outcome after hematopoietic stem cell transplantation.
    Gratwohl A, Brand R, McGrath E, van Biezen A, Sureda A, Ljungman P, Baldomero H, Chabannon C, Apperley J, Joint Accreditation Committee (JACIE) of the International Society for Cellular Therapy and the European Group for Blood and Marrow Transplantation, and the European Leukemia Net.
    Haematologica; 2014 May 20; 99(5):908-15. PubMed ID: 24488562
    [Abstract] [Full Text] [Related]

  • 12. [Comparison of autologous and allogeneic hematopoietic stem cell transplantation for 140 patients with de novo acute leukemia in first complete remission].
    Wang HH, Feng SZ, Wang M, Wei JL, Jiang EL, Zhang L, Huang Y, Zhou SY, Liu QG, Qiu LG, Han MZ, Yan WW.
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jul 20; 25(7):389-92. PubMed ID: 15355688
    [Abstract] [Full Text] [Related]

  • 13. The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products.
    Gratwohl A, Baldomero H, Frauendorfer K, Rocha V, Apperley J, Niederwieser D, Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT), European Group for Blood and Marrow Transplantation EBMT (JACIE).
    Bone Marrow Transplant; 2008 Apr 20; 41(8):687-705. PubMed ID: 18084334
    [Abstract] [Full Text] [Related]

  • 14. Haematopoietic stem cell transplantation (HSCT) in Europe 2002. Changes in indication and impact of team density. A report of the EBMT activity survey.
    Gratwohl A, Schmid O, Baldomero H, Horisberger B, Urbano-Ispizua A, Accreditation Committee of the European Group for Blood and Marrow Transplantation.
    Bone Marrow Transplant; 2004 Nov 20; 34(10):855-75. PubMed ID: 15517006
    [Abstract] [Full Text] [Related]

  • 15. Economics and Outcome After Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study.
    Gratwohl A, Sureda A, Baldomero H, Gratwohl M, Dreger P, Kröger N, Ljungman P, McGrath E, Mohty M, Nagler A, Rambaldi A, de Elvira CR, Snowden JA, Passweg J, Apperley J, Niederwieser D, Stijnen T, Brand R, Joint Accreditation Committee (JACIE) of the International Society for Cellular Therapy (ISCT) and the European Society for Blood and Marrow Transplantation (EBMT) and the European Leukemia Net (ELN).
    EBioMedicine; 2015 Dec 20; 2(12):2101-9. PubMed ID: 26844291
    [Abstract] [Full Text] [Related]

  • 16. Comparison of characteristics of bacterial bloodstream infection between adult patients with allogeneic and autologous hematopoietic stem cell transplantation.
    Hong J, Moon SM, Ahn HK, Sym SJ, Park YS, Park J, Cho YK, Cho EK, Shin DB, Lee JH.
    Biol Blood Marrow Transplant; 2013 Jun 20; 19(6):994-9. PubMed ID: 23571460
    [Abstract] [Full Text] [Related]

  • 17. Comparison of atrial fibrillation prevalence and in-hospital cardiovascular outcomes between patients undergoing allogeneic versus autologous hematopoietic stem cell transplantation: insights from the national inpatient sample.
    Krishan S, Asad ZUA, Quiroga D, Ghazi SM, Quartermaine C, Braunstein Z, Kola-Kehinde O, Shaaban A, Habib A, Khan S, Cheng R, Brammer JE, Addison D.
    Sci Rep; 2024 Jul 22; 14(1):16829. PubMed ID: 39039091
    [Abstract] [Full Text] [Related]

  • 18. The clinical and economic impact of cytomegalovirus infection in recipients of hematopoietic stem cell transplantation.
    Webb BJ, Harrington R, Schwartz J, Kammerer J, Spalding J, Lee E, Dodds B, Kaufusi S, Goodman BE, Firth SD, Martin G, Sorensen J, Hoda D.
    Transpl Infect Dis; 2018 Oct 22; 20(5):e12961. PubMed ID: 29975816
    [Abstract] [Full Text] [Related]

  • 19. The role of hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma.
    Kako S, Izutsu K, Kato K, Kim SW, Mori T, Fukuda T, Kobayashi N, Taji H, Hashimoto H, Kondo T, Sakamaki H, Morishima Y, Kato K, Suzuki R, Suzumiya J, Adult Lymphoma Working Group of the Japanese Society for Hematopoietic Cell Transplantation.
    Am J Hematol; 2015 Feb 22; 90(2):132-8. PubMed ID: 25382792
    [Abstract] [Full Text] [Related]

  • 20. Clinical Impact of Pretransplant Multidrug-Resistant Gram-Negative Colonization in Autologous and Allogeneic Hematopoietic Stem Cell Transplantation.
    Forcina A, Lorentino F, Marasco V, Oltolini C, Marcatti M, Greco R, Lupo-Stanghellini MT, Carrabba M, Bernardi M, Peccatori J, Corti C, Ciceri F.
    Biol Blood Marrow Transplant; 2018 Jul 22; 24(7):1476-1482. PubMed ID: 29501780
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.